Auswahl der wichtigsten Publikationen

  1. Rödel C, Grabenbauer GG, Kühn R, Papadopoulos T, Dunst J, Meyer M, Schrott KM, Sauer R. Combined modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 2002;20:3061-3071.

  2. Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003;21:3098-3104.

  3. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess C, Karstens JH, Liersch T, Schmidberger H, Raab R, for the German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer. N Engl J Med 2004;351:1731-40.

  4. Rödel F, Hoffmann J, Distel L, Herrmann M, Noistering T, Papadopoulos T, Sauer R, Rödel C. Survivin as a radio-resistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005;65:4881-87.

  5. Rödel C, Martus P, Papadopoulos T, Füzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23: 8688-96.

  6. Weiss C, Wolze C, Engehausen DG, Ott O, Ott JO, Krause FS, Schrott KM, Dunst J, Sauer R, Rödel C. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: An alternative to intravesical therapy or early cystectomy. J Clin Oncol 2006;24:2318-24.

  7. Rödel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 2006;24:5536-44.

  8. Rödel C, Liersch T, Hermann RM, Arnold D, Reese T, Hipp M, Fürst A, Schwella N, Bieker M, Hellmich G, Ewald H, Haier J, Lordick F, Flentje M, Sülberg H, Hohenberger W, Sauer R.  Multicenter phase II trial of chemoradiotherapy with oxaliplatin for rectal cancer. J Clin Oncol 2007;25:110-7.

  9. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H,  Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow up of 11 years. J Clin Oncol 2012;30:1926-33.

  10. Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab R, Sülberg H, Wittekind C,  Potapov S, Staib L, Hess C, Weigang-Köhler K, Grabenbauer G, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R. Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomized phase 3 trial. Lancet Oncol 2012;13:679-87.

  11. Fokas E, Liersch T, Fietkau R, Hohenberger W, Beissbarth T, Hess C, Becker H, Ghadimi M, Mrak K, Merkel S, Raab HR, Sauer R, Wittekind C, Rödel C. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: Updated results of the CAO/ARO/AIO-94 trial after a median follow-up of 11 years. J Clin Oncol 2014,32:1554-62.

  12. Rödel C, Graeven U, Fietkau R, Hohenberger W, Hothorn T, Arnold D, Hofheinz RD, Ghadimi M, Wolff HA, Lang-Welzenbach M, Raab HR, Wittekind C, Ströbel P, Staib L, Wilhelm M, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, Liersch T; German Rectal Cancer Study Group. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2015;16:979-89.

  13. Fokas E, Ströbel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer GG, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Rödel C. Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer. J Natl Cancer Inst 2017, epub ahead of print.

  14. Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W,  Jacobasch L, Weitz J, Folprecht G, Schlenka-Lange A, Flentje M, Germer CT, Grützmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rödel C, German Rectal Cancer Study Group. Randomized Phase II Trial on Chemoradiotherapy plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. J Clin Oncol 2019;37:3212-3222.

  15. Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of sex with toxic effects, treatment adherence, and oncologic outcomes in the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 Phase 3 randomized clinical trials of rectal cancer. JAMA Oncol 2019; epub ahead of print.

  16. Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, Rödel C. Outcome measures in multimodal rectal cancer trials. Lancet Oncol 2020;21:e252-e264.

Originalarbeiten (chronologisch)

  1. Rödel C, Fietkau R, Grabenbauer GG, Keilholz L, Martus P, Kessler R, Sauer R. Akuttoxizität der simultanen Radiochemotherapie des Rektumkarzinoms. Strahlenther Onkol 1997;173:414-20.

  2. Wendt TH, Grabenbauer GG, Rödel C, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A. Simultaneous radio-chemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-24.

  3. Grüner A, Grabenbauer GG, Rödel C, Weidenbecher M, Martus P, Iro H, Sauer R. Nasopharynxkarzinom: Nur Bestrahlung oder simultane Radiochemotherapie? Strahlenther Onkol 1999;175:591-96.

  4. Rödel C, Grabenbauer GG, Matzel KL, Schick C, Fietkau R, Papadopoulos T, Martus P, Hohenberger W, Sauer R. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000;43:312-19.

  5. Rödel C, Grabenbauer GG, Rödel F, Birkenhake S, Kühn R, Martus P, Fürsich D, Papadoupolos T, Dunst J, Sauer R. Apoptosis, p53, Ki-67 and bcl-2: possible predictors for successful bladder preservation by transurethral resection and radiochemotherapy. Int J Radiat Oncol Biol Phys 2000;46:1213-21.

  6. Grabenbauer GG, Schuchardt U, Buchfelder M, Rödel C, Gusek G, Marx M, Doerr HG, Fahlbusch R, Huk WJ, Wenzel D, S